{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:06:14Z","timestamp":1791108374902,"version":"4.1.0"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Burkholderia cepacia<\/jats:named-content>\n            complex (Bcc) pulmonary infections in people living with cystic fibrosis (CF) are difficult to treat because of the extreme intrinsic resistance of most isolates to a broad range of antimicrobials. Fosmidomycin is an antibacterial and antiparasitic agent that disrupts the isoprenoid biosynthesis pathway, a precursor to hopanoid biosynthesis. Hopanoids are involved in membrane stability and contribute to polymyxin resistance in Bcc bacteria. Checkerboard MIC assays determined that although isolates of the Bcc species\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">B. multivorans<\/jats:named-content>\n            were highly resistant to treatment with fosmidomycin or colistin (polymyxin E), antimicrobial synergy was observed in certain isolates when the antimicrobials were used in combination. Treatment with fosmidomycin decreased the MIC of colistin for isolates as much as 64-fold to as low as 8 \u03bcg\/ml, a concentration achievable with colistin inhalation therapy. A liquid chromatography-tandem mass spectrometry technique was developed for the accurate quantitative determination of underivatized hopanoids in total lipid extracts, and bacteriohopanetetrol cyclitol ether (BHT-CE) was found to be the dominant hopanoid made by\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">B. multivorans<\/jats:named-content>\n            . The amount of BHT-CE made was significantly reduced upon fosmidomycin treatment of the bacteria. Uptake assays with 1-\n            <jats:italic>N<\/jats:italic>\n            -phenylnaphthylamine were used to determine that dual treatment with fosmidomycin and colistin increases membrane permeability, while binding assays with boron-dipyrromethene-conjugated polymyxin B illustrated that the addition of fosmidomycin had no impact on polymyxin binding. This work indicates that pharmacological suppression of membrane hopanoids with fosmidomycin treatment can increase the susceptibility of certain clinical\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">B. multivorans<\/jats:named-content>\n            isolates to colistin, an agent currently in use to treat pulmonary infections in CF patients.\n          <\/jats:p>","DOI":"10.1128\/aac.02705-14","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T06:08:33Z","timestamp":1403590113000},"page":"5211-5219","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":34,"title":["Fosmidomycin Decreases Membrane Hopanoids and Potentiates the Effects of Colistin on Burkholderia multivorans Clinical Isolates"],"prefix":"10.1128","volume":"58","author":[{"given":"Rebecca J.","family":"Malott","sequence":"first","affiliation":[{"name":"Centre for Understanding and Preventing Infection in Children, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy D.","family":"Lee","sequence":"additional","affiliation":[{"name":"Centre for Understanding and Preventing Infection in Children, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor J.","family":"Hird","sequence":"additional","affiliation":[{"name":"Centre for Understanding and Preventing Infection in Children, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan F.","family":"Dalleska","sequence":"additional","affiliation":[{"name":"Environmental Analysis Center, California Institute of Technology, Pasadena, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E. A.","family":"Zlosnik","sequence":"additional","affiliation":[{"name":"Centre for Understanding and Preventing Infection in Children, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne K.","family":"Newman","sequence":"additional","affiliation":[{"name":"Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California, USA"},{"name":"Howard Hughes Medical Institute, Pasadena, California, USA"},{"name":"Division of Geological and Planetary Sciences, California Institute of Technology, Pasadena, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Speert","sequence":"additional","affiliation":[{"name":"Centre for Understanding and Preventing Infection in Children, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2007.03706.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03237.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80993-2"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1085"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2011.00159"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.2217\/17460913.2.2.153"},{"key":"e_1_3_2_8_2","volume-title":"Abstracts of the International Burkholderia cepacia Working Group Meeting","author":"Bumford AA","year":"2010","unstructured":"BumfordAASpilkerTLiPumaJ. 2010. Epidemiology of Burkholderia infection in U.S. CF patients, abstr 1A, p 1. Abstracts of the International Burkholderia cepacia Working Group Meeting, 21 to 24 April 2010, Seattle, WA."},{"key":"e_1_3_2_9_2","volume-title":"Abstracts of the International Burkholderia cepacia Working Group Meeting","author":"Zlosnik JE","year":"2011","unstructured":"ZlosnikJEHenryDASpeertDP. 2011. Burkholderia cepacia complex infections in Vancouver and British Columbia from 1981 to 2010, abstr A1, p 1, Abstracts of the International Burkholderia cepacia Working Group Meeting, 14 to 16 April 2011, Prague, Czech Republic."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.50.11.1194"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.37.7.2201-2208.1999"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00063198-200111000-00013"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1758-2229.2010.00222.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.14.3.500"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.4.539"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1991.tb00735.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.188.6.2073-2080.2006"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.008532"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00602-11"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-373"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.05979-11"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001140050592"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.2174\/157019310792246436"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6968.2000.tb08974.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi200113y"},{"key":"e_1_3_2_26_2","first-page":"154","article-title":"Isoprenoid biosynthesis as a novel target for antibacterial and antiparasitic drugs","volume":"5","author":"Rohmer M","year":"2004","unstructured":"RohmerMGrosdemange-BilliardCSeemannMTritschD. 2004. Isoprenoid biosynthesis as a novel target for antibacterial and antiparasitic drugs. Curr. Opin. Investig. Drugs 5:154\u2013162.","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.04.020"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0802.010163"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.2.910-913.2000"},{"key":"e_1_3_2_30_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard\u2014ninth edition","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard\u2014ninth edition. M07\u2013A9, vol 32. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.34.876"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201002-0203OC"},{"key":"e_1_3_2_33_2","volume-title":"Lipid separation using UPLC with charged surface hybrid technology","author":"Isaac G","year":"2011","unstructured":"IsaacGMcDonaldSAstaritaG. 2011. Lipid separation using UPLC with charged surface hybrid technology. Waters Corporation, Milford, MA."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.11.2648"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq054"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01366-10"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01434-10"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-51-7-533"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1054\/drup.2000.0152"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki461"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-70"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl838"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.2911"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.4.546"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01620-08"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.09.010"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02705-14","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02705-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:46:47Z","timestamp":1645483607000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02705-14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1128\/AAC.02705-14"],"URL":"https:\/\/doi.org\/10.1128\/aac.02705-14","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"2014-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-06-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-08-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}